Gil M. Labrucherie

Companies

• Septerna, Inc.Chief financial officer Jan 7, 2025 to now¹
• ACELYRIN, Inc.Chief financial officer Aug 3, 2023 to now²
• Rezolute, Inc.Board member Nov 27, 2019 to now³
• Nektar TherapeuticsChief operating officer Oct 2, 2019 to May 17, 2022⁴
• Nektar TherapeuticsChief financial officer Jun 3, 2016 to May 17, 2022⁵
• Nektar TherapeuticsGeneral counsel Apr 4, 2007 to May 18, 2016⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NTNektar Therapeutics NKTR312,905 shares⁷$11.4M at $36.45May 16, 2022
• SSepterna, Inc. SEPN40,000 shares⁸$1.5M at $36.66Feb 27, 2025
• RRezolute, Inc. RZLT109,072 shares⁹$403.0K at $3.69Nov 21, 2025
• AACELYRIN, Inc.47,013 shares¹⁰Oct 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 19, 2025Granted 21,000 shares of Rezolute, Inc.⁹
• Jun 10, 2025Granted 9,000 shares of Rezolute, Inc.¹¹
• Feb 27, 2025Bought 3,718 shares at $5.85 of Septerna, Inc.⁸
• Feb 25, 2025Bought 6,282 shares at $5.59 of Septerna, Inc.⁸
• Feb 21, 2025Bought 5,000 shares at $5.85 of Septerna, Inc.¹²
• Feb 20, 2025Bought 14,500 shares at $5.88 of Septerna, Inc.¹²
• Feb 19, 2025Bought 10,500 shares at $5.51 of Septerna, Inc.¹²
• Feb 16, 2025Granted 25,500 shares of Rezolute, Inc.¹³
• Oct 4, 2023Other 40,763 shares of ACELYRIN, Inc.¹⁰
• May 16, 2022Sold 17,448 shares at $3.95 of Nektar Therapeutics⁷
• May 15, 2022Granted 28,750 shares of Nektar Therapeutics⁷
• May 4, 2022Bought 52,631 shares at $3.80 of Rezolute, Inc.¹⁴
• May 4, 2022Bought 52,631 shares at $3.80 of Rezolute, Inc.¹⁵
• Feb 16, 2022Sold 7,579 shares at $10.95 of Nektar Therapeutics¹⁶
• Dec 16, 2021Granted 52,950 shares of Nektar Therapeutics¹⁷
• Nov 18, 2021Sold 3,000 shares at $12.69 of Nektar Therapeutics¹⁸
• Nov 16, 2021Sold 21,149 shares at $13.16 of Nektar Therapeutics¹⁸
• Nov 15, 2021Granted 40,150 shares of Nektar Therapeutics¹⁹